NeurAxis (NRXS) Competitors

InspireMD (NYSE:NSPR) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, community ranking, institutional ownership, analyst recommendations and media sentiment.

Do institutionals and insiders believe in NSPR or NRXS?

44.8% of InspireMD shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 34.1% of InspireMD shares are owned by company insiders. Comparatively, 26.4% of NeurAxis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Which has more risk and volatility, NSPR or NRXS?

InspireMD has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, NeurAxis has a beta of 3.34, indicating that its share price is 234% more volatile than the S&P 500.

Does the MarketBeat Community prefer NSPR or NRXS?

InspireMD received 4 more outperform votes than NeurAxis when rated by MarketBeat users. However, 100.00% of users gave NeurAxis an outperform vote while only 4.95% of users gave InspireMD an outperform vote.

Company	Underperform	Outperform
InspireMD	Outperform Votes 5 4.95%	Underperform Votes 96 95.05%
NeurAxis	Outperform Votes 1 100.00%	Underperform Votes No Votes

Which has preferable earnings & valuation, NSPR or NRXS?

NeurAxis has lower revenue, but higher earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$7.03M	10.90	-$19.92M	-$0.79	-3.16
NeurAxis	$2.93M	5.65	-$14.63M	-$1.19	-1.93

Do analysts rate NSPR or NRXS?

InspireMD presently has a consensus target price of $4.50, suggesting a potential upside of 80.00%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than NeurAxis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is NSPR or NRXS more profitable?

InspireMD has a net margin of -413.96% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
NeurAxis	-492.76%	N/A	-641.25%

Does the media favor NSPR or NRXS?

In the previous week, NeurAxis had 2 more articles in the media than InspireMD. MarketBeat recorded 3 mentions for NeurAxis and 1 mentions for InspireMD. InspireMD's average media sentiment score of 0.00 beat NeurAxis' score of -0.01 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NeurAxis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

InspireMD beats NeurAxis on 12 of the 18 factors compared between the two stocks.